Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A. Paniculata/A. Chilensis in URTI
NCT04955327Phase 3Completed
- Sponsor
- Vedic Lifesciences
- Start
- Mar 2021
- Primary completion
- Feb 2022
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 3 trial of andrographis paniculata in upper respiratory tract infection (URI), sponsored by Vedic Lifesciences. Started Mar 2021; status: completed.
02
Drugs
andrographis paniculata
03
Conditions
upper respiratory tract infection (URI)
Beyond the preview
Go deeper on NCT04955327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04955327.